Human anaplasmosis (ehrlichiosis);Humana anaplazmoza (erlihioza) - Prikaz bolesnika

Acta Medica Croatica

Volumn 60, Issue 5, 2006, Pages 411-419

  Mišić Majerus, Ljiljana ^a,d   Bujić, Nevenka ^c,e   Madarić, Vesna ^c,e   Avšič Županc, Tatjana ^b   Milinković, Stjepan ^c,e  

^a Djelatnost za Infektivne Bolesti   (Croatia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c Ordinacija Op e Medicine   (Croatia)

^d General Hospital Tomislav Bardek   (Croatia)

^e Outpatient Clinic   (Croatia)

Author keywords

Confirmed and probable human anaplasmosis; Tick borne diseases

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ANAMNESIS; ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; ANTIBODY TITER; ARTICLE; BLOOD SMEAR; BORRELIA BURGDORFERI; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROATIA; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; FEMALE; GIEMSA STAIN; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; SEROCONVERSION; TICK BITE; TICK BORNE DISEASE;

ADOLESCENT; ADULT; ANAPLASMOSIS; EHRLICHIOSIS; FEMALE; FEVER; HUMANS; MALE;

EID: 33846070024     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Dumler JS, Barbet AF, Bakken CP i sur. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001; 51: 2145-65.
2. Chen S, Dumler JS, Bakken JS, Walker AR. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994; 32: 589-95.
3. Dumler JS, Bakken JS. Human ehrlichiosis: newly recognized infections transmitted by ticks. Annu Rev Med 1998; 49: 201-13.
4. Walker DH, Dumler JS. Human monocytic and granulocytic ehrlichioses. Discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist. Arch Pathol Lab Med 1997; 121: 785-91.
5. Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA 1994; 272: 212-18.
6. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995; 20: 1102-10.
7. Aguero-Rosenfeld ME, Horowitz HW, Wormser GP i sur. Human granulocytic ehrlichiosis, a case series from a single medical center in New York State. Ann Intern Med 1996; 125: 904-8.
8. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275: 199-205.
9. Blanco JR, Oteo JA. Human granulocytic ehrlichiosis in Europe. Clin Microbiol Infect 2002; 8: 763-72.
10. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T i sur. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin Infect Dis 1998; 27: 424-28.
11. Arnez M, Petrovec M, Lotric-Furlan S, Avsic-Zupanc T, Strle F. First European pediatric case of human granulocytic ehrlichiosis. J Clin Microbiol 2001; 39: 4591-92.
12. Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious treat. Clin Infect Dis 2001; 32: 897-928.
13. Alberdi MP, Walker AR, Paxton EA, Sumption KJ. Natural prevalence of infection with Ehrlichia (Cytoecetes) phagocytophila of Ixodes ricinus ticks in Scotland. Vet Parasitol 1998; 78: 203-13.
14. Cinco M, Padovan D, Murgia R, Heldtander M, Engvall EO. Detection of HGE agent-like Ehrlichia in Ixodes ricinus ticks in northern Italy by PCR. Wien Klin Wochenschr 1998; 110: 898-900.
15. Oteo JA, Gil H, Barral M i sur. Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. Epidemiol Infect 2001; 127: 353-58.
16. Petrovec M, Summer JW, Nicholson WL i sur. Identity of ehrlichial DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis in Slovenia. J Clin Microbiol 1999; 37: 209-10.
17. Liz JS, Anderes L, Summer JW i sur. PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerlan I. J Clin Microbiol 2000; 38: 1002-7.
18. Ogden NH, Bown K, Horrocks BK, Woldehiwet Z, Benneth M. Granulocytic Ehrlichia infection in ixodid ticks and mammals in woodlands and uplands of the U. K. Med Vet Entomol 1998; 12: 423-29.
19. Petrovec M, Bidovec A, Summer JW, Nicholson WL, Childs JE, Avsic-Zupanc T. Infection with Anaplasma phagocytophila in cervids from Slovenia: evidence of two genotypic lineages. Wien Klin Wochenschr 2002; 114: 641-47.
20. Stuen S, Van De Pol I, Bergstrom K, Schouls LM. Identification of Anaplasma phagocytophila (formerly Ehrlichia phagocytophila) variants in blood from sheep in Norway. J Clin Microbiol 2002; 40: 3192-97.
21. Martin ME, Bunnel JE, Dumler JS. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J Infect Dis 2000; 181: 374-78.
22. Martin ME, Caspersen K, Dumler JS. Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am J Pathol 2001; 158: 1881-88.
23. Ogden NM, Woldehiwet Z, Hart CA. Granulocytic ehrlichiosis: an emerging or rediscovered tick-borne disease? J Med Microbiol 1998; 47: 475-82.
24. Hardalo CJ, Quagliarello V, Dumler JS. Human granulocytic ehrlichiosis in Connecticut: report of a fatal case. Clin Infect Dis 1995; 21: 910-14.
25. Wallace BJ, Brady G, Ackman DM i sur. Human granulocytic ehrlichiosis in New York Arch Intern Med 1998; 158: 769-73.
26. Bakken JS, Aguero-Rosenfeld ME, Tilden RL i sur. Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. Clin Infect Dis 2001; 32: 862-70.
27. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, Strle F. Human granulocytic ehrlichiosis in Slovenia. Ann N Y Acad Sci 2003; 990: 279-84.
28. Nicholson WL, Comar JA, Summer JW i sur. An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol 1997; 35: 1510-16.
29. Klein MB, Nelson CM, Goodman JL. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob Agents Chemother 1997; 41: 76-79.
30. Horowitz HW, Hsieh TG, Aguero-Rosenfeld ME i sur. Antimicrobial susceptibility of Ehrlichia phagocytophila. Antimicrob Agents Chemother 2001; 45: 786-88.
31. McQuiston JH, Paddock CD, Holman RC, Childs JE. The human ehrlichiosis in the United States. Emerg Infect Dis 1999; 5: 635-42.
32. Brouqui P, Dumler JS, Lienhard R, Brossard M, Raoult D. Human granulocytic ehrlichiosis in Europe. Lancet 1995; 346: 782-83.
33. Petrovec M, Lotric-Furlan S, Avsic-Zupanc T i sur. Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol 1997; 35: 1556-59.
34. van Dobbenburgh A, van Dam AP, Fikrig E. Human granulocytic ehrlichiosis in western Europe. N Engl J Med 1999; 340: 1214-16.
35. Oteo JA, Blanco JR, Martinez de Artola V, Ibbara V. First report of human granulocytic ehrlichiosis from southern Europe (Spain). Emerg Infect Dis 2000; 6: 430-31.
36. Ruscio M, Cinco M. Human granulocytic ehrlichiosis in Italy: first report on two confirmed cases. Ann N Y Acad Sci 2003; 990: 350-52.
37. Karlsson U, Bjoersdorff A, Massung RF, Christensson B. Human granulocytic ehrlichiosis: a clinical case in Scandinavia. Scand J Infect Dis 2001; 33: 73-74.
38. Tylewska-Wierzbanowska S, Chmielewski T, Kondrusik M, Hermanowska-Szpakowicz T, Sawicki W, Sulek K. First case of acute human granulocytic ehrlichiosis in Poland. Eur J Clin Microbiol Infect Dis 2001; 20: 196-98.
39. Misic-Majerus Lj, Bujic N, Madjaric V, Avsic-Zupanc T. First description of the human granulocytic ehrlichiosis in Croatia. Clin Microb Infect 2000; 6 (Suppl. 1): 194-95.
40. Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recom Rep 1997; 46 (RR-10): 1-55.
41. Walker DH. Consensus workshop on diagnosis of human ehrlichiosis. Bull Am Soc Rikettsiol 1999; 2: 1-8.
42. Walker DH and the Task Force on Consensus Approach for Ehrlichiosis. Diagnosing human ehrlichiosis: current status and recommendations. ASM News 2000; 66: 287-90.
43. Broqui P, Salvo E, Dumler JS, Raoult D. Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay. Clin Diagn Lab Immunol 2001; 8: 199-202.
44. Bakken JS, Krueth JH, Lund T, Malkowitch D, Asanovich K, Dumler JS. Exposure to deer blood may be a cause of human granulocytic ehrlichiosis. Clin Infect Dis 1996; 23: 198.
45. Horowitz HW, Kilchevsky E, Haber S i sur. Perinatal transmission of the agent of the human granulocytic ehrlichiosis. N Engl J Med 1998; 339: 375-8.
46. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis 2000; 31: 554-60.
47. Pancholi P, Kolbert CP, Mitchell PD i sur. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis 1995; 172: 1007-12.
48. Hilton E, DeVoti J, Benoch JL i sur. Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am J Med 1999; 106: 404-9.
49. Laferl H, Hogrefe W, Kock T, Pichler H. A further case of acute human granulocytic ehrlichiosis in Slovenia. Eur J Clin Microbiol Infect Dis 1999; 18: 385-S6.
50. Ratnasamy N, Everett ED, Roland WE, McDonald G, Caldwell CW. Central nervous system manifestations of human ehrlichiosis. Clin Infect Dis 1996; 23: 314-19.
51. Olano JP, Walker DH. Human ehrlichiosis. Med Clin North Am 2002; 86: 375-92.
52. Bakken JS, Tilden RL, Walls JJ, Dimler JS. Influence of occupation, preexisting illnesses and chronic medication use on the severity of illness of human granulocytic ehrlichiosis. U: Raoult D, Brouqui P, ur. Rickettsia and rickettsial diseases at the turn of the third millennium. Paris: Elsevier, 1999, 195-98.
53. Bjoersdorff A, Berglund J, Kristiansen BE, Soderstrom C, Eliasson I. Varying clinical picture and course of human granulocytic ehrlichiosis. Twelve Scandinavian cases of the new tick-borne zoonosis are presented. Lakartidningen 1999; 96: 4200-4.
54. Wong S, Grady Lj. Ehrlichia infection as a cause of severe respiratory distress. N Engl J Med 1996; 334: 273.
55. Lee FS, Chu FK, Tackley M, Wu AD, Atri A, Wessels MR. Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old women. Clin Infect Dis 2000; 31: 1288-91.
56. Jahangir A, Kolbert C, Edwards W, Mitchell P, Dumler JS, Persing DH. Fatal pancarditis associated with human granulocytic Ehrlichiosis in a 44-year-old man. Clin Infect Dis 1998; 27: 1424-27.
57. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T i sur. Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin Diagn Lab Imunol 2001; 8: 899-903.
58. Hossain D, Aguero-Rosenfeld ME, Horowitz HW i sur. Clinical and laboratory evaluation of a culture-confirmed case of human granulocytic ehrlichiosis. Conn Med 1999; 63: 265-70.
59. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, Logar M, Strle F. Epidemiological, clinical and laboratory distinction between human granulocytic ehrlichiosis and the initial phase of tick-borne encephalitis. Wien Klin Wochenschr 2002; 114: 636-40.
60. Edelman DC, Dumler JS. Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol Diagn 1996; 1: 41-49.
61. Massung RF, Slater KG. Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum. J Clin Microbiol 2003; 41: 717-22.
62. Lodes MJ, Mohamath R, Regnalds LD i sur. Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteins. J Clin Microbiol 2001; 39: 2466-76.
63. Bakken JS, Dumler JS. Ehrlichia species. U: Yu V, Merrigan T, Barriere S, ur. Antimicrobial therapy and vaccines. Baltimore: Williams and Willkins, 1998: 546-51.
64. Bakken JS, Dumler JS. Ehrlichiosis. U: Cunha BA, Maderazo EG, Spielman A, ur. Tick-borne infectious diseases. New York: Marcel Dekker, 2000, 139-58.
65. Abrahamson JS, Givner LB. Should tetracycline be contraindicated for therapy of presumed Rocky Mountain spotted fever in children less than 9 years of age? Pediatrics 1990; 86: 123-24.
66. Horowitz HW, Kilchewsky E, Haber S i sur. Perinatal transmission of the agent of human granulocytic ehrlichiosis. N Engl J Med 1998; 339: 375-78.
67. Buitrago MI, Ijdo JW, Rinaudo P i sur. Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin Infect Dis 1998; 27: 213-15.